Pages that link to "Q33893738"
Jump to navigation
Jump to search
The following pages link to Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations (Q33893738):
Displaying 50 items.
- Lewy Body Pathology in Alzheimer's Disease (Q22241400) (← links)
- Synaptic vesicle trafficking and Parkinson's disease (Q24302024) (← links)
- Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets (Q24306916) (← links)
- Alpha-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling (Q24311523) (← links)
- The N-terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes (Q24316619) (← links)
- α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation (Q24605589) (← links)
- Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease (Q26767264) (← links)
- Direct and/or Indirect Roles for SUMO in Modulating Alpha-Synuclein Toxicity (Q26799306) (← links)
- Alpha-synuclein structure, functions, and interactions (Q28075526) (← links)
- Alpha-synuclein and neurodegenerative diseases (Q28204386) (← links)
- The role of α-synuclein and tau hyperphosphorylation-mediated autophagy and apoptosis in lead-induced learning and memory injury (Q28386471) (← links)
- Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain (Q28509158) (← links)
- Altered Fatty Acid Composition of Dopaminergic Neurons Expressing α-Synuclein and Human Brains with α-Synucleinopathies (Q28591852) (← links)
- Multiple β-sheet molecular dynamics of amyloid formation from two ABl-SH3 domain peptides (Q30009967) (← links)
- Protein Misfolding in Lipid-Mimetic Environments. (Q30376386) (← links)
- Switch region for pathogenic structural change in conformational disease and its prediction (Q30384993) (← links)
- Biophysics of α-synuclein membrane interactions. (Q30405705) (← links)
- Biophysical insights into how surfaces, including lipid membranes, modulate protein aggregation related to neurodegeneration. (Q30427825) (← links)
- Essential role of ubiquitin and TSG101 protein in formation and function of the central supramolecular activation cluster (Q30495533) (← links)
- Biochemical characterization of the core structure of alpha-synuclein filaments (Q30827075) (← links)
- Direct visualization of the gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus (Q30858845) (← links)
- Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers (Q31165000) (← links)
- Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation (Q33267617) (← links)
- Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra (Q33269934) (← links)
- Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations (Q33836384) (← links)
- alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins (Q33929879) (← links)
- The lipid-binding domain of wild type and mutant alpha-synuclein: compactness and interconversion between the broken and extended helix forms (Q34107467) (← links)
- Parkinson's disease and other alpha-synucleinopathies (Q34270992) (← links)
- Parkinson disease: etiology, pathogenesis and future of gene therapy (Q34355457) (← links)
- Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast (Q34573229) (← links)
- Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation (Q34648491) (← links)
- Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1. (Q34739881) (← links)
- Alpha-synuclein and presynaptic function: implications for Parkinson's disease. (Q34995107) (← links)
- Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease (Q35058359) (← links)
- Alpha-synuclein: its biological function and role in neurodegenerative diseases (Q35148669) (← links)
- Influence of RNA interference on the mitochondrial subcellular localization of alpha-synuclein and on the formation of Lewy body-like inclusions in the cytoplasm of human embryonic kidney 293 cells induced by the overexpression of alpha-synuclein (Q35160746) (← links)
- Parkinson's disease, cortical dysfunction, and alpha-synuclein (Q35161124) (← links)
- Neuritic alterations and neural system dysfunction in Alzheimer's disease and dementia with Lewy bodies (Q35570812) (← links)
- Alpha-synuclein: normal function and role in neurodegenerative diseases. (Q35749928) (← links)
- Phosphorylation of α-synuclein protein at Ser-129 reduces neuronal dysfunction by lowering its membrane binding property in Caenorhabditis elegans (Q35802054) (← links)
- α-synuclein, LRRK2 and their interplay in Parkinson's disease. (Q35932488) (← links)
- Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C. (Q36141456) (← links)
- α-Synuclein and nonhuman primate models of Parkinson's disease (Q36157306) (← links)
- Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons. (Q36293826) (← links)
- Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein (Q36476930) (← links)
- Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders (Q36484413) (← links)
- Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD. (Q36512589) (← links)
- Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner (Q36887384) (← links)
- Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms (Q37119779) (← links)
- Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease (Q37151410) (← links)